Skip to Content
  • Revenues ($M)
    $19,959
  • Revenue Percent Change
    1.7%
  • Profits ($M)
    $2,408
  • Profits Percent Change
    0.7%
  • Assets ($M)
    $35,569
  • Employees
    41,275
  • Market Value — as of March 31, 2016 ($M)
    $79,535
  • Previous Rank
    151
  • Morning Consult Brand Index
    B-

The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
David A. Ricks
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Indianapolis, IN
Websitehttp://www.lilly.com
Years on Fortune 500 List22
Employees41,275

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$19,9591.7%
Profits ($M)$2,4080.7%
Assets ($M)$35,569-
Total Stockholder Equity ($M)$14,571-
Market Value — as of March 31, 2016 ($M)$79,535-

Profit Ratios

Profit as % of Revenues12.1%
Profits as % of Assets6.8%
Profits as % of Stockholder Equity16.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.26
EPS % Change (from 2014)1.3%
EPS % Change (5 year annual rate)-13.2%
EPS % Change (10 year annual rate)2.2%

Total Return

Total Return to Investors (2015)25.3%
Total Return to Investors (5 year, annualized)23.8%
Total Return to Investors (10 year, annualized)8.4%